Relapsed Refractory Acute Lymphoblastic Leukemia Clinical Trials in Riyadh, Riyadh Region

CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia